These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22564831)

  • 21. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases.
    Harada T; Akiyama Y; Kurashima A; Nagai H; Tsuyuguchi K; Fujii T; Yano S; Shigeto E; Kuraoka T; Kajiki A; Kobashi Y; Kokubu F; Sato A; Yoshida S; Iwamoto T; Saito H
    J Clin Microbiol; 2012 Nov; 50(11):3556-61. PubMed ID: 22915613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Sun Q; Liao X; Wang C; Jiang G; Yang J; Zhao J; Huang H; Wang G; Li H
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708979
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
    Nash KA; Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1367-76. PubMed ID: 19171799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
    Zhang Z; Lu J; Song Y; Pang Y
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):31-34. PubMed ID: 29089153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
    Koh WJ; Hong G; Kim SY; Jeong BH; Park HY; Jeon K; Kwon OJ; Lee SH; Kim CK; Shin SJ
    Antimicrob Agents Chemother; 2013 May; 57(5):2281-5. PubMed ID: 23478956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.
    Almeida D; Nuermberger E; Tyagi S; Bishai WR; Grosset J
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4261-6. PubMed ID: 17938193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs.
    Brown-Elliott BA; Vasireddy S; Vasireddy R; Iakhiaeva E; Howard ST; Nash K; Parodi N; Strong A; Gee M; Smith T; Wallace RJ
    J Clin Microbiol; 2015 Apr; 53(4):1211-5. PubMed ID: 25653399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
    Miyake N; Chong Y; Nishida R; Takenaka K; Kato K; Miyamoto T; Aono A; Takaki A; Mitarai S; Shimoda S; Shimono N; Akashi K
    J Infect Chemother; 2018 Jan; 24(1):78-81. PubMed ID: 28988958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
    Park J; Cho J; Lee CH; Han SK; Yim JJ
    Clin Infect Dis; 2017 Feb; 64(3):301-308. PubMed ID: 28011609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
    Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
    BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
    Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
    J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea.
    Kim J; Sung H; Park JS; Choi SH; Shim TS; Kim MN
    Int J Tuberc Lung Dis; 2016 Jan; 20(1):109-14. PubMed ID: 26688536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subspecies identification for Mycobacterium abscessus group].
    Gui J; Li J; Hong C; Wang F
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):512-6. PubMed ID: 25262692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
    Nie W; Duan H; Huang H; Lu Y; Chu N
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):517-21. PubMed ID: 25262693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
    Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
    Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns.
    Kim HY; Kim BJ; Kook Y; Yun YJ; Shin JH; Kim BJ; Kook YH
    Microbiol Immunol; 2010 Jun; 54(6):347-53. PubMed ID: 20536733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Arghittu M; Girelli D; Biffi A; D'Accico M; Daccò V; Gambazza S; Pizzamiglio G; Trovato A; Tortoli E; Colombo C; Cariani L
    New Microbiol; 2020 Jul; 43(3):127-132. PubMed ID: 32656572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?
    Hanson KE; Slechta ES; Muir H; Barker AP
    J Clin Microbiol; 2014 May; 52(5):1705-7. PubMed ID: 24554745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.